Capricor Therapeutics, Inc. (CAPR) Social Stream
Capricor Therapeutics Inc (CAPR) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CAPR.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 2 | $14 | $12 | $13 | $3.45 | 276.81% |
| 2022-01-31 | 2 | $18 | $12 | $15 | $3.45 | 334.78% |
The Trend in the Analyst Price Target
Over the past 12 months, CAPR's average price target has gone up $3.
CAPR reports an average of 184.36% for its upside potential over the past 34 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-06-05 | 0 | 12 | 9 | 10.5 | 3.86 | 172.02% |
| 2021-06-21 | 0 | 12 | 9 | 10.5 | 5.41 | 94.09% |
| 2021-08-24 | 0 | 12 | 9 | 10.5 | 4.12 | 154.85% |
| 2021-11-10 | 2 | 14 | 12 | 13.0 | 3.51 | 270.37% |
| 2022-01-31 | 2 | 18 | 12 | 15.0 | 3.57 | 320.17% |
CAPR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CAPR as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, Capricor Therapeutics Inc's number of analysts covering the stock is greater than 9.38% of them.
- In the context of all US stocks, Capricor Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 185.25% of them.
- In the context of all US stocks, Capricor Therapeutics Inc's average analyst price target is higher than 28.8% of them.
- In terms of how Capricor Therapeutics Inc fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 55.3% of that group.
Stocks similar to Capricor Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are BPTS, BNOX, and BLRX.
Is CAPR a Buy, Hold or Sell? See the POWR Ratings now!